ArticleScientific reports2017

Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.

Mohammad-Reza Nejadmoghaddam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.